Evidence map›Paper›PMID 40540561›Full record

ArticleScience advances2025

Plagioclase under compression: A path to diaplectic glass and maskelynite.

Tianqi Xie, Sean R Shieh, Stella Chariton, Mauritz van Zyl, Ricardo D Rodriguez, Vitali B Prakapenka, Dongzhou Zhang

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tianqi XieDepartment of Earth Sciences, University of Western Ontario, London, ON N6K 5B7, Canada.ORCID 0000-0003-3706-6583
Sean R ShiehDepartment of Earth Sciences, University of Western Ontario, London, ON N6K 5B7, Canada.ORCID 0000-0001-7573-3039
Stella CharitonCenter for Advanced Radiation Sources, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-5522-0498
Mauritz van ZylDepartment of Earth Sciences, University of Western Ontario, London, ON N6K 5B7, Canada.ORCID 0000-0002-1200-0986
Ricardo D RodriguezDepartment of Earth Sciences, University of Western Ontario, London, ON N6K 5B7, Canada.ORCID 0000-0002-9227-7511
Vitali B PrakapenkaCenter for Advanced Radiation Sources, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9270-2330
Dongzhou ZhangCenter for Advanced Radiation Sources, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-6679-892X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diaplectic glass and maskelynite in shocked plagioclase serve as key diagnostic features for high level of shock metamorphism in impact craters and meteorites. However, their formation mechanisms remain unclear and have long been argued, mainly due to the lack of phase diagram for plagioclase with extended pressure-temperature conditions. We report the stabilities of labradorite and anorthite at pressure up to 65 gigapascals and temperature up to 4000 kelvin. Our experimental results reveal the pressure-temperature conditions for amorphization, decomposition, and melting of labradorite and anorthite. The boundary between amorphous plagioclase and crystalline high-pressure phases in our phase diagram indicate diaplectic glass can form at 1300 to 1500 kelvin, and the melting line suggests that maskelynite can be generated above 3000 kelvin at high pressures. Formation conditions of diaplectic glass and maskelynite in plagioclase-bearing rocks are also suggested by the combination of phase diagram and shock Hugoniot data. These findings will advance our understanding of the bombardment history on rocky planetary surfaces.

Identifiers

PMID40540561
PMCPMC12180495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.